Published
Antidiabetika - inzulíny a kombinace XI. - Tresiba
Notice number: 00577183-2026
KEY INFORMATION
- Submission deadline
- • Sep 21, 2026
- Location
- 🇨🇿 Czechia
- Contracting authority
- Institut klinické a experimentální medicíny
- Accepted Languages
- Czech
- Tender type
- Goods
- Contract Value
- Published date
- Aug 20, 2026
TENDER DESCRIPTION
The subject of this public contract is the regular supply of medicinal products containing the active substance insulin degludec (ATC group A10AE06) for the treatment of patients in the approved indications in accordance with the SPC valid as of the date of submission of bids. The subject of this public contract is the regular supply of medicinal products containing the active substance insulin degludec (ATC group A10AE06) for the treatment of patients in the approved indications in accordance with the SPC valid as of the date of submission of bids.
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 3 FILES
- Submission PortalLINK
- non-restricted-documentLINK
- TED PortalLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.